According to Cocrystal Pharma 's latest financial reports and stock price the company's current Operating Margin is -478.64%. At the end of 2020 the company had an Operating Margin of -479.05%.
Year | Operating Margin | Change |
---|---|---|
2020 | -479.05% | -34.72% |
2019 | -733.84% | |
2015 | -83,807.69% | 4895.16% |
2014 | -1,677.78% | |
2012 | -46.33% | 7.08% |
2011 | -43.27% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -104.78% | ๐บ๐ธ USA |
Merck MRK | 27.73% | -105.79% | ๐บ๐ธ USA |
Nature's Sunshine Products NATR | 7.16% | -101.50% | ๐บ๐ธ USA |
USANA USNA | 14.38% | -103.00% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.